4.5 Article

Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation

Francesco Cappelli et al.

Summary: In a large multicentric cohort of CA patients, the prevalence and incidence rate of AEs was high, with a significant proportion of events occurring despite anticoagulation therapy or in patients in sinus rhythm. A higher CHA2DS2-VASc score may identify patients at risk of AEs, even among those in sinus rhythm.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)

Article Cardiac & Cardiovascular Systems

Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis

Eoin Donnellan et al.

AMERICAN JOURNAL OF CARDIOLOGY (2020)

Letter Cardiac & Cardiovascular Systems

Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis

Francesco Cappelli et al.

CIRCULATION-HEART FAILURE (2020)

Article Medicine, General & Internal

Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis

Alberto Aimo et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

Management of Arrhythmias in Cardiac Amyloidosis

Shaun Giancaterino et al.

JACC-CLINICAL ELECTROPHYSIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Treatment of cardiac transthyretin amyloidosis: an update

Michele Emdin et al.

EUROPEAN HEART JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology

Petar M. Seferovic et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Letter Cardiac & Cardiovascular Systems

Real-world versus trial patients with transthyretin amyloid cardiomyopathy

Marco Canepa et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Article Medicine, General & Internal

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Mathew S. Maurer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Meeting Abstract Biochemistry & Molecular Biology

Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful?

Fabian Aus Dem Siepen et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2017)

Article Cardiac & Cardiovascular Systems

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore et al.

CIRCULATION (2016)

Article Cardiac & Cardiovascular Systems

AL (Light-Chain) Cardiac Amyloidosis A Review of Diagnosis and Therapy

Rodney H. Falk et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Article Biochemistry & Molecular Biology

Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role

Simone Longhi et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)

Article Cardiac & Cardiovascular Systems

Cardiac amyloidosis: the great pretender

Claudio Rapezzi et al.

HEART FAILURE REVIEWS (2015)

Review Cardiac & Cardiovascular Systems

Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis

Morie A. Gertz et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)